Endothelial dysfunction, smoking and COPD

N. Karoli, A. Rebrov (Saratov, Russia)

Source: Annual Congress 2004 - COPD and lung cancer: genetics and pathogenesis
Session: COPD and lung cancer: genetics and pathogenesis
Session type: Thematic Poster Session
Number: 2016
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Karoli, A. Rebrov (Saratov, Russia). Endothelial dysfunction, smoking and COPD. Eur Respir J 2004; 24: Suppl. 48, 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial dysfunction at the patients with COPD with pulmonary hypertension
Source: Eur Respir J 2001; 18: Suppl. 33, 415s
Year: 2001

Tobacco smoking and pulmonary endothelial dysfunction
Source: Eur Respir J 2007; 30: Suppl. 51, 607s
Year: 2007

Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007

Endothelial dysfunction as systemic effects of COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 652s
Year: 2006

Endothelial dysfunction of patients with pulmonary hypertension
Source: Eur Respir J 2002; 20: Suppl. 38, 25s
Year: 2002

Evaluation of endothelial dysfunction at the patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 316s
Year: 2004

Correction of endothelial dysfunction in patients with COPD, IPF
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010


The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011

Endothelial dysfunction in patients with bronchial asthma with and without arterial hypertension
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009


Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Endothelial function and vascular biomarkers in COPD
Source: Annual Congress 2008 - Pulmonary vascular biology
Year: 2008

Endothelial dysfunction in patients with occupational lung diseases
Source: Annual Congress 2010 - Pulmonary circulation II
Year: 2010


Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma
Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous
Year: 2008

Correction of endothelial dysfunction in patients with COPD and concomitant arterial hypertension
Source: International Congress 2015 – COPD: interesting notes
Year: 2015

Left ventricular dysfunction in patients with COPD: Inflammation and endothelial dysfunction
Source: Annual Congress 2013 –Guidelines and exacerbations
Year: 2013

Endothelial function in patients with tobacco and biomass smoke-related COPD
Source: International Congress 2017 – Extrapulmonary comorbidities in COPD
Year: 2017


Systemic vasomotor form of endothelial dysfunction in smoker and ex-smoker COPD patients
Source: Annual Congress 2010 - Smoking related diseases, damages due to environmental tobacco smoke and smoking control strategies
Year: 2010


Determinants of endothelial function in patients with COPD
Source: Eur Respir J 2013; 42: 1194-1204
Year: 2013



Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007

Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016